Chlamydia

Study results from Vrije University Amsterdam provide new insights into chlamydia

Published in Vaccine Weekly, January 13th, 2010

According to recent research published in the journal Drugs of Today, "An integrated, multidisciplinary effort is needed to achieve a greater understanding of the immunopothogenesis of uragenital and ocular Chlamydia trachomatis infections to combat this infection successfully, to prevent long-term complications and to develop a vaccine."

"The contribution of molecular epidemiology and host-pathogen genomics to the understanding of diseases caused by C. trachomatis was explored in depth by the ICTI Consortium, which was first introduced in the Netherlands in December 2004 at the First Annual Amsterdam Chlamydia Meeting (AACM) and was the subject of a special...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2010-01-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry